Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 2Suspended 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lung Neoplasms 22Leukemia, Myeloid, Acute 21Breast Neoplasms 19Neoplasm Metastasis 16Pancreatic Neoplasms 15Multiple Myeloma 14Prostatic Neoplasms 12Melanoma 12Lymphoma 11Colorectal Neoplasms 11Carcinoma, Renal Cell 11Carcinoma, Non-Small-Cell Lung 11Burkitt Lymphoma 10Triple Negative Breast Neoplasms 9Urinary Bladder Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Myelodysplastic Syndromes 8Mouth Neoplasms 8Glioma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Oropharyngeal Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 7Laryngeal Neoplasms 7Fallopian Tube Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma 7Sarcoma 6Nasopharyngeal Carcinoma 6Endometrial Neoplasms 6

Interventions

Specimen Handling 3Standard of Care 2Practice Guidelines as Topic 2Patient Reported Outcome Measures 1Data Collection 1CVnCoV COVID-19 vaccine 1COH04S1 COVID-19 vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
COVID-19 × Specimen Handling × 30 days × Clear all
NCT04387656 2026-06-03

NCI COVID-19 in Cancer Patients, NCCAPS Study

National Cancer Institute (NCI)

Active not recruiting
1,877 enrolled

COVID-19, Neoplasm Metastasis

NCT05672355 2026-05-20

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 2 Suspended
80 enrolled
LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05228275 2026-05-18

Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer

Children's Oncology Group

Active not recruiting
549 enrolled

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon âš¡